SEC Form 4 · accession 0001437749-15-000380
OMNI BIO PHARMACEUTICAL, INC. · OMBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce E. Schneider
Officer — Chief Executive Officer · Director
Period of report
Jan 1, 2015
Accepted (ET)
Jan 7, 2015 · 3:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001389870
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy)F1 | $0.37 | Jan 1, 2015 | A | 1,500,000 | A | — | Jan 1, 2022 | Common Stock | 1,500,000 | 3,426,210 | D |
Explanation of responses
- F1The warrant vests annually in three equal installments beginning January 1, 2015.